Pharmacokinetics of ADS-5102 (amantadine) Extended Release Capsules Administered Once-Daily at Bedtime for the Treatment of Dyskinesia

被引：0
|
作者：
Hauser, Robert [1 ]
Pahwa, Rajesh [2 ]
Wargin, William [3 ]
Souza-Prien, Cindy [4 ]
McClure, Natalie [4 ]
Patni, Rajiv [4 ]
Went, Gregory [4 ]
机构：
[1] Univ South Florida, Tampa, FL USA
[2] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[3] Nuventra Pharma Serv Inc, Raleigh, NC USA
[4] Adamas Pharmaceut Inc, Emeryville, CA USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P2.043
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy of once-daily extended-release gabapentin for the treatment of painful diabetic neuropathy
    Schwartz, Sherwyn L.
    Berner, Bret
    Cramer, Marilou
    Chiang, Yu-Kun
    Biton, Victor
    Sandercock, David
    DIABETES, 2007, 56 : A161 - A161
  • [42] PHARMACOKINETICS AND CLINICAL OUTCOMES OF DE NOVO RENAL TRANSPLANTATIONWITH ONCE-DAILY TACROLIMUS EXTENDED RELEASE (TER)
    Yoshida, Kazunari
    Tomizawa, Jun
    Ishii, Daisuke
    Kobayashi, Masahiro
    Takeuchi, Yasuo
    Wakai, Haruki
    Noguchi, Fumino
    Ikea, Masae
    Yago, Kazuo
    Baba, Shiro
    TRANSPLANT INTERNATIONAL, 2011, 24 : 256 - 256
  • [43] A Randomized Study of the Effects of Food on the Pharmacokinetics of Once-Daily Extended-Release Hydromorphone in Healthy Volunteers
    Moore, Kenneth Todd
    St-Fleur, Dominique
    Marricco, Nadia Cardillo
    Ariyawansa, Jay
    Page, Veronique
    Natarajan, Jayalakshmi
    Morelli, Gaetano
    Richarz, Ute
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (11): : 1571 - 1579
  • [44] Efficacy and safety of once-daily dexmethylphenidate extended-release capsules in pediatric patients with attention-deficit disorder
    Greenhill, LL
    Litt, F
    Jiang, H
    Guerra, Y
    Muniz, R
    ANNALS OF NEUROLOGY, 2004, 56 : S107 - S107
  • [45] Pharmacokinetics comparison between two formulations of lamotrigine: Once-daily extended-release vs twice daily immediate-release tablets
    Ali, Imran
    Oliver-Willwong, R.
    Tompson, D.
    Hammer, A.
    Vuong, A.
    Messenheimer, J.
    EPILEPSIA, 2007, 48 : 369 - 370
  • [46] Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and Dyskinesia
    Robert A. Hauser
    Shyamal H. Mehta
    Daniel Kremens
    Dustin Chernick
    Andrea E. Formella
    Neurology and Therapy, 2021, 10 : 739 - 751
  • [47] Long-Term Safety and Tolerability of Once-Daily Mesalamine Extended-Release Capsules in Patients With Ulcerative Colitis
    Lichtenstein, Gary R.
    Barrett, Andrew C.
    Bortey, Enoch
    Paterson, Craig
    Forbes, William P.
    GASTROENTEROLOGY, 2013, 144 (05) : S432 - S432
  • [48] Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson's Disease and Dyskinesia
    Hauser, Robert A.
    Mehta, Shyamal H.
    Kremens, Daniel
    Chernick, Dustin
    Formella, Andrea E.
    NEUROLOGY AND THERAPY, 2021, 10 (02) : 739 - 751
  • [49] Response to "Once-daily venlafaxine extended release (XR) vs. fluoxetine for the treatment of depression"
    Rudolph, RL
    Feiger, AD
    JOURNAL OF AFFECTIVE DISORDERS, 2001, 66 (01) : 97 - 98
  • [50] Efficacy and safety of an extended-release formulation of Fluvastatin for once-daily treatment of primary hypercholesterolemia
    Ballantyne, CM
    McKenney, J
    Trippe, BS
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (07): : 759 - 763
12345